Nula Therapeutics, Inc.
Biotechnology · St. Petersburg, FL
BiotechnologySEC Form D
Nula Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 18, 2026, reporting $7,399,003 raised.
Incorporated in Delaware and based in St. Petersburg, FL, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Nula Therapeutics, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Christopher ShepardExecutive Officer · Director
- Jarod RutledgeDirector
- Nils ReggeDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised